Commerce Bank Makes New Investment in Kenvue Inc. $KVUE

Key Points

• Commerce Bank acquired 128,840 Kenvue shares during the second quarter, valued at approximately $2.46 million. Institutional investors collectively own 97.64% of the company.
• Kenvue reported quarterly revenue of $3.96 billion, up 3% year over year, but EPS of $0.31 narrowly missed analysts’ $0.32 estimate. Analysts project full-year EPS of $1.14.
• The company pays a quarterly dividend of $0.21, equivalent to an annualized yield of about 4.3%. Analysts maintain a consensus “Hold” rating, with an average price target of $19.27.

Commerce Bank acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 128,840 shares of the company's stock, valued at approximately $2,462,000.

Several other institutional investors have also modified their holdings of the stock. Arrowstreet Capital Limited Partnership purchased a new stake in Kenvue during the 2nd quarter worth approximately $6,528,000. Jump Financial LLC lifted its position in shares of Kenvue by 210.6% in the second quarter. Jump Financial LLC now owns 54,823 shares of the company's stock valued at $1,147,000 after acquiring an additional 37,170 shares in the last quarter. AXA S.A. boosted its stake in shares of Kenvue by 21.1% in the second quarter. AXA S.A. now owns 48,892 shares of the company's stock worth $1,023,000 after acquiring an additional 8,524 shares during the last quarter. NewEdge Advisors LLC boosted its stake in shares of Kenvue by 219.1% in the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company's stock worth $2,040,000 after acquiring an additional 66,930 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of Kenvue by 0.6% during the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company's stock worth $39,217,000 after purchasing an additional 10,885 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Kenvue Price Performance

KVUE stock opened at $19.41 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The business has a 50 day simple moving average of $19.08 and a 200-day simple moving average of $18.21. The firm has a market capitalization of $37.27 billion, a PE ratio of 22.30, a price-to-earnings-growth ratio of 1.36 and a beta of 0.47. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $21.63.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The company had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. During the same period in the prior year, the business posted $0.29 EPS. Kenvue's revenue for the quarter was up 3.0% compared to the same quarter last year. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be paid a $0.21 dividend. This is a boost from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.3%. Kenvue's dividend payout ratio is 96.55%.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Barclays increased their price objective on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. UBS Group lowered their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 11th. Zacks Research lowered shares of Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. Wall Street Zen cut shares of Kenvue from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Finally, Weiss Ratings raised shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Monday, June 15th. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $19.27.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.